Evidence map›Paper›PMID 20691925›Full record

ArticleUltrasound in medicine & biology2010

Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion.

Mario L Fabiilli, Kevin J Haworth, Ian E Sebastian, Oliver D Kripfgans, Paul L Carson, J Brian Fowlkes

Abstract read
In one paragraph

Article in Ultrasound in medicine & biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Article
  2. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Smart nanogels for cancer treatment from the perspective of functional groups.Frontiers in bioengineering and biotechnology · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mario L FabiilliDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA. mfabiill@umich.edu
Kevin J Haworth
Ian E Sebastian
Oliver D Kripfgans
Paul L Carson
J Brian Fowlkes

Funding

VASCULAR BUBBLE GENERATION FOR DIAGNOSIS AND THERAPYR01EB000281 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARSON, PAUL L · 2002 to 2008
$1.6M
NIBIB NIH HHS 5R01EB000281NIBIB NIH HHS R01 EB000281
6 · The paper itself

Abstract

Ultrasound-mediated delivery systems have mainly focused on microbubble contrast agents as carriers of drugs or genetic material. This study uses micron-sized, perfluoropentane (PFP) emulsions as carriers of chlorambucil (CHL), a lipophilic chemotherapeutic. The release of CHL is achieved via acoustic droplet vaporization (ADV), whereby the superheated emulsion is converted into gas bubbles using ultrasound. Emulsions were made using an albumin shell and soybean oil as the CHL carrier. The ratio of the PFP to soybean oil phases in the droplets and the fraction of droplets that vaporize per ultrasound exposure were shown to correlate with droplet diameter. A 60-min incubation with the CHL-loaded emulsion caused a 46.7% cellular growth inhibition, whereas incubation with the CHL-loaded emulsion that was exposed to ultrasound at 6.3 MHz caused an 84.3% growth inhibition. This difference was statistically significant (p < 0.01), signifying that ADV can be used as a method to substantially enhance drug delivery.

Indexed as

SonicationAnimalsAntineoplastic Agents, AlkylatingCell SurvivalChlorambucilCHO CellsCricetinaeCricetulusDrug Delivery SystemsEmulsionsFluorocarbonsPentanesAntineoplastic Agents, AlkylatingChlorambucilEmulsionsFluorocarbonsPentanesperfluoropentane

Identifiers

PMID20691925
PMCPMC2933659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.